NCT05110235

Brief Summary

Percutaneous endoscopic gastrostomy (PEG) is currently the chosen minimally invasive, endoscopic procedure for medium- and long-term enteral feeding in cases who need palliative care. The presented study evaluated geriatric (\> 65-year-old) PEG-applied patients at our institution.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2017

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 13, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

November 5, 2021

Completed
Last Updated

November 5, 2021

Status Verified

October 1, 2021

Enrollment Period

3.3 years

First QC Date

October 13, 2021

Last Update Submit

October 26, 2021

Conditions

Nutrient DeficiencyGastrostomy

Keywords

GeriatricsNutritionPEGGastrostomy

Outcome Measures

Primary Outcomes (2)

  • Hemoglobin (gr/dl)

    30 th day hemoglobin levels after PEG application

    30 days

  • Albumin (gr/dl)

    30 th day albumin levels after PEG application

    30 days

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We retrospectively assessed the medical datum of PEG applied \>65-year-old patients at our institution between December 2017 and March 2021. And, we excluded the patients who were not treated in our palliative care center. Table 1. shows the contraindications for PEG placement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Okan University Hospital

Istanbul, 34734, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor, Assistant Professor, Principal investigator

Study Record Dates

First Submitted

October 13, 2021

First Posted

November 5, 2021

Study Start

December 1, 2017

Primary Completion

March 30, 2021

Study Completion

May 30, 2021

Last Updated

November 5, 2021

Record last verified: 2021-10

Locations

TU(1)